Heart Failure pp 299-305 | Cite as

Bridge to Recovery (BTR)

  • Juliane K. ViereckeEmail author
Part of the Cardiovascular Medicine book series (CVM)


the use of a durable device to allow recovery from chronic cardiac failure (at least 3 months in duration).


  1. 1.
    Muller J, Wallukat G, Weng YG, Dandel M, Spiegelsberger S, Semrau S, et al. Weaning from mechanical cardiac support in patients with idiopathic dilated cardiomyopathy. Circulation. 1997;96(2):542–9.PubMedGoogle Scholar
  2. 2.
    Hetzer R, Muller J, Weng Y, Wallukat G, Spiegelsberger S, Loebe M. Cardiac recovery in dilated cardiomyopathy by unloading with a left ventricular assist device. Ann Thorac Surg. 1999;68(2):742–9.PubMedGoogle Scholar
  3. 3.
    Levin HR, Oz MC, Catanese KA, Rose EA, Burkhoff D. Transient normalization of systolic and diastolic function after support with a left ventricular assist device in a patient with dilated cardiomyopathy. J Heart Lung Transplant. 1996;15(8):840–2.PubMedGoogle Scholar
  4. 4.
    Levin HR, Oz MC, Chen JM, Packer M, Rose EA, Burkhoff D. Reversal of chronic ventricular dilation in patients with end-stage cardiomyopathy by prolonged mechanical unloading. Circulation. 1995;91(11):2717–20.PubMedGoogle Scholar
  5. 5.
    Burkhoff D, Klotz S, Mancini DM. LVAD-induced reverse remodeling: basic and clinical implications for myocardial recovery. J Card Fail. 2006;12(3):227–39.PubMedGoogle Scholar
  6. 6.
    Madigan JD, Barbone A, Choudhri AF, Morales DL, Cai B, Oz MC, et al. Time course of reverse remodeling of the left ventricle during support with a left ventricular assist device. J Thorac Cardiovasc Surg. 2001;121(5):902–8.PubMedGoogle Scholar
  7. 7.
    Drakos SG, Wever-Pinzon O, Selzman CH, Gilbert EM, Alharethi R, Reid BB, et al. Magnitude and time course of changes induced by continuous-flow left ventricular assist device unloading in chronic heart failure: insights into cardiac recovery. J Am Coll Cardiol. 2013;61(19):1985–94.PubMedGoogle Scholar
  8. 8.
    Birks EJ. Molecular changes after left ventricular assist device support for heart failure. Circ Res. 2013;113(6):777–91.PubMedPubMedCentralGoogle Scholar
  9. 9.
    Hall JL, Fermin DR, Birks EJ, Barton PJ, Slaughter M, Eckman P, et al. Clinical, molecular, and genomic changes in response to a left ventricular assist device. J Am Coll Cardiol. 2011;57(6):641–52.PubMedPubMedCentralGoogle Scholar
  10. 10.
    Akhter SA, D’Souza KM, Malhotra R, Staron ML, Valeroso TB, Fedson SE, et al. Reversal of impaired myocardial beta-adrenergic receptor signaling by continuous-flow left ventricular assist device support. J Heart Lung Transplant. 2010;29(6):603–9.PubMedPubMedCentralGoogle Scholar
  11. 11.
    Ogletree ML, Sweet WE, Talerico C, Klecka ME, Young JB, Smedira NG, et al. Duration of left ventricular assist device support: effects on abnormal calcium cycling and functional recovery in the failing human heart. J Heart Lung Transplant. 2010;29(5):554–61.PubMedGoogle Scholar
  12. 12.
    Klotz S, Barbone A, Reiken S, Holmes JW, Naka Y, Oz MC, et al. Left ventricular assist device support normalizes left and right ventricular beta-adrenergic pathway properties. J Am Coll Cardiol. 2005;45(5):668–76.PubMedGoogle Scholar
  13. 13.
    Klotz S, Burkhoff D, Garrelds IM, Boomsma F, Danser AH. The impact of left ventricular assist device-induced left ventricular unloading on the myocardial renin-angiotensin-aldosterone system: therapeutic consequences? Eur Heart J. 2009;30(7):805–12.PubMedGoogle Scholar
  14. 14.
    Frazier OH, Benedict CR, Radovancevic B, Bick RJ, Capek P, Springer WE, et al. Improved left ventricular function after chronic left ventricular unloading. Ann Thorac Surg. 1996;62(3):675–81. discussion 81-2PubMedGoogle Scholar
  15. 15.
    Saito S, Matsumiya G, Sakaguchi T, Miyagawa S, Yamauchi T, Kuratani T, et al. Cardiac fibrosis and cellular hypertrophy decrease the degree of reverse remodeling and improvement in cardiac function during left ventricular assist. J Heart Lung Transplant. 2010;29(6):672–9.PubMedGoogle Scholar
  16. 16.
    Ambardekar AV, Walker JS, Walker LA, Cleveland JC Jr, Lowes BD, Buttrick PM. Incomplete recovery of myocyte contractile function despite improvement of myocardial architecture with left ventricular assist device support. Circ Heart Fail. 2011;4(4):425–32.PubMedPubMedCentralGoogle Scholar
  17. 17.
    Mann DL, Barger PM, Burkhoff D. Myocardial recovery and the failing heart: myth, magic, or molecular target? J Am Coll Cardiol. 2012;60(24):2465–72.PubMedPubMedCentralGoogle Scholar
  18. 18.
    Frazier OH, Myers TJ. Left ventricular assist system as a bridge to myocardial recovery. Ann Thorac Surg. 1999;68(2):734–41.PubMedGoogle Scholar
  19. 19.
    Komoda T, Komoda S, Dandel M, Weng Y, Hetzer R. Explantation of INCOR left ventricular assist device after myocardial recovery. J Card Surg. 2008;23(6):642–7.PubMedGoogle Scholar
  20. 20.
    Mueller J, Wallukat G, Weng Y, Dandel M, Ellinghaus P, Huetter J, et al. Predictive factors for weaning from a cardiac assist device. An analysis of clinical, gene expression, and protein data. J Heart Lung Transplant. 2001;20(2):202.PubMedGoogle Scholar
  21. 21.
    Loebe M, Weng Y, Muller J, Dandel M, Halfmann R, Spiegelsberger S, et al. Successful mechanical circulatory support for more than two years with a left ventricular assist device in a patient with dilated cardiomyopathy. J Heart Lung Transplant. 1997;16(11):1176–9.PubMedGoogle Scholar
  22. 22.
    Liang H, Lin H, Weng Y, Dandel M, Hetzer R. Prediction of cardiac function after weaning from ventricular assist devices. J Thorac Cardiovasc Surg. 2005;130(6):1555–60.PubMedGoogle Scholar
  23. 23.
    Hetzer R, Muller JH, Weng Y, Meyer R, Dandel M. Bridging-to-recovery. Ann Thorac Surg. 2001;71(3 Suppl):S109–13. discussion S14-5PubMedGoogle Scholar
  24. 24.
    Dandel M, Weng Y, Siniawski H, Stepanenko A, Krabatsch T, Potapov E, et al. Heart failure reversal by ventricular unloading in patients with chronic cardiomyopathy: criteria for weaning from ventricular assist devices. Eur Heart J. 2011;32(9):1148–60.PubMedGoogle Scholar
  25. 25.
    Estep JD, Chang SM, Bhimaraj A, Torre-Amione G, Zoghbi WA, Nagueh SF. Imaging for ventricular function and myocardial recovery on nonpulsatile ventricular assist devices. Circulation. 2012;125:2265–77.PubMedGoogle Scholar
  26. 26.
    Drakos SG, Mehra MR. Clinical myocardial recovery during long-term mechanical support in advanced heart failure: insights into moving the field forward. J Heart Lung Transplant. 2016;35(4):413–20.PubMedGoogle Scholar
  27. 27.
    Birks EJ, Tansley PD, Hardy J, George RS, Bowles CT, Burke M, et al. Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med. 2006;355(18):1873–84.Google Scholar
  28. 28.
    Birks EJ, George RS, Hedger M, Bahrami T, Wilton P, Bowles CT, et al. Reversal of severe heart failure with a continuous-flow left ventricular assist device and pharmacological therapy: a prospective study. Circulation. 2011;123(4):381–90.PubMedGoogle Scholar
  29. 29.
    Drakos SG, Terrovitis JV, Anastasiou-Nana MI, Nanas JN. Reverse remodeling during long-term mechanical unloading of the left ventricle. J Mol Cell Cardiol. 2007;43(3):231–42.PubMedGoogle Scholar
  30. 30.
    Aaronson KD, Pagani FD, Maybaum SW, Feldman DS, Bogaev RC, O’Connell JB, Boyce SW, McGee EW, Sun BC, Goldstein DJ, Frazier OH, Myles JD, Weatherwax KJ, Basobas L, McGowan L, Farrar DJ, Yacoub MH, Birks EJ, Miller LW. Combination therapy with pulsatile left ventricular assist device, heart failure medication and clenbuterol in chronic heart failure: results from HARPS. J Heart Lung Transplant. 2011;30:S8–9. abstract.Google Scholar
  31. 31.
    Patel SR, Saeed O, Murthy S, Bhatia V, Shin JJ, Wang D, et al. Combining neurohormonal blockade with continuous-flow left ventricular assist device support for myocardial recovery: a single-arm prospective study. J Heart Lung Transplant. 2013;32(3):305–12.PubMedGoogle Scholar
  32. 32.
    Mancini DM, Beniaminovitz A, Levin H, Catanese K, Flannery M, Ditullio M, et al. Low incidence of myocardial recovery after left ventricular assist device implantation in patients with chronic heart failure. Circulation. 1998;98(22):2383–9.PubMedGoogle Scholar
  33. 33.
    Farrar DJ, Holman WR, McBride LR, Kormos RL, Icenogle TB, Hendry PJ, et al. Long-term follow-up of Thoratec ventricular assist device bridge-to-recovery patients successfully removed from support after recovery of ventricular function. J Heart Lung Transplant. 2002;21(5):516–21.PubMedGoogle Scholar
  34. 34.
    Wever-Pinzon O, Drakos SG, McKellar SH, Horne BD, Caine WT, Kfoury AG, et al. Cardiac recovery during long-term left ventricular assist device support. J Am Coll Cardiol. 2016;68(14):1540–53.PubMedGoogle Scholar
  35. 35.
    Topkara VK, Garan AR, Fine B, Godier-Furnemont AF, Breskin A, Cagliostro B, et al. Myocardial recovery in patients receiving contemporary left ventricular assist devices: results from the interagency registry for mechanically assisted circulatory support (INTERMACS). Circ Heart Fail. 2016;9(7).Google Scholar
  36. 36.
    Drakos SG, Kfoury AG, Stehlik J, Selzman CH, Reid BB, Terrovitis JV, et al. Bridge to recovery: understanding the disconnect between clinical and biological outcomes. Circulation. 2012;126(2):230–41.PubMedPubMedCentralGoogle Scholar
  37. 37.
    Dandel M, Weng Y, Siniawski H, Potapov E, Lehmkuhl HB, Hetzer R. Long-term results in patients with idiopathic dilated cardiomyopathy after weaning from left ventricular assist devices. Circulation. 2005;112(9 Suppl):I37–45.PubMedGoogle Scholar
  38. 38.
    Goldstein DJ, Maybaum S, MacGillivray TE, Moore SA, Bogaev R, Farrar DJ, et al. Young patients with nonischemic cardiomyopathy have higher likelihood of left ventricular recovery during left ventricular assist device support. J Card Fail. 2012;18(5):392–5.PubMedGoogle Scholar
  39. 39.
    Givertz MM, Mann DL. Epidemiology and natural history of recovery of left ventricular function in recent onset dilated cardiomyopathies. Curr Heart Fail Rep. 2013;10(4):321–30.PubMedGoogle Scholar
  40. 40.
    Dandel M, Weng Y, Siniawski H, Potapov E, Drews T, Lehmkuhl HB, et al. Prediction of cardiac stability after weaning from left ventricular assist devices in patients with idiopathic dilated cardiomyopathy. Circulation. 2008;118(14 Suppl):S94–105.PubMedGoogle Scholar
  41. 41.
    Pan S, Aksut B, Wever-Pinzon OE, Rao SD, Levin AP, Garan AR, et al. Incidence and predictors of myocardial recovery on long-term left ventricular assist device support: results from the united network for organ sharing database. J Heart Lung Transplant. 2015;34(12):1624–9.PubMedGoogle Scholar
  42. 42.
    Basuray A, French B, Ky B, Vorovich E, Olt C, Sweitzer N, et al. Response to letter regarding article, “heart failure with recovered ejection fraction: clinical description, biomarkers, and outcomes”. Circulation. 2015;131(6):e344.PubMedGoogle Scholar
  43. 43.
    Krabatsch T, Schweiger M, Dandel M, Stepanenko A, Drews T, Potapov E, et al. Is bridge to recovery more likely with pulsatile left ventricular assist devices than with nonpulsatile-flow systems? Ann Thorac Surg. 2011;91(5):1335–40.PubMedGoogle Scholar
  44. 44.
    Klotz S, Deng MC, Stypmann J, Roetker J, Wilhelm MJ, Hammel D, et al. Left ventricular pressure and volume unloading during pulsatile versus nonpulsatile left ventricular assist device support. Ann Thorac Surg. 2004;77(1):143–9. discussion 9-50PubMedGoogle Scholar
  45. 45.
    Thohan V, Stetson SJ, Nagueh SF, Rivas-Gotz C, Koerner MM, Lafuente JA, et al. Cellular and hemodynamics responses of failing myocardium to continuous flow mechanical circulatory support using the DeBakey-noon left ventricular assist device: a comparative analysis with pulsatile-type devices. J Heart Lung Transplant. 2005;24(5):566–75.PubMedGoogle Scholar
  46. 46.
    Haft J, Armstrong W, Dyke DB, Aaronson KD, Koelling TM, Farrar DJ, et al. Hemodynamic and exercise performance with pulsatile and continuous-flow left ventricular assist devices. Circulation. 2007;116(11 Suppl):I8–15.PubMedGoogle Scholar
  47. 47.
    John R, Boyle A, Pagani F, Miller L. Physiologic and pathologic changes in patients with continuous-flow ventricular assist devices. J Cardiovasc Transl Res. 2009;2(2):154–8.PubMedGoogle Scholar
  48. 48.
    Guan Y, Karkhanis T, Wang S, Rider A, Koenig SC, Slaughter MS, et al. Physiologic benefits of pulsatile perfusion during mechanical circulatory support for the treatment of acute and chronic heart failure in adults. Artif Organs. 2010;34(7):529–36.PubMedGoogle Scholar
  49. 49.
    Kato TS, Chokshi A, Singh P, Khawaja T, Cheema F, Akashi H, et al. Effects of continuous-flow versus pulsatile-flow left ventricular assist devices on myocardial unloading and remodeling. Circ Heart Fail. 2011;4(5):546–53.PubMedPubMedCentralGoogle Scholar
  50. 50.
    Jacobs S, Geens J, Rega F, Burkhoff D, Meyns B. Continuous-flow left ventricular assist devices induce left ventricular reverse remodeling. J Heart Lung Transplant. 2013;32(4):466–8.PubMedGoogle Scholar
  51. 51.
    Feldman DS, Moazami N, Adamson PB, Vierecke J, Raval N, et al. The utility of a wireless implantable hemodynamic monitoring system in patients requiring mechanical circulatory support. ASAIO J. 2018;64(3):301–8.PubMedGoogle Scholar
  52. 52.
    Klotz S, Danser AH, Foronjy RF, Oz MC, Wang J, Mancini D, et al. The impact of angiotensin-converting enzyme inhibitor therapy on the extracellular collagen matrix during left ventricular assist device support in patients with end-stage heart failure. J Am Coll Cardiol. 2007;49(11):1166–74.PubMedGoogle Scholar
  53. 53.
    Feldman D, Elton TS, Menachemi DM, Wexler RK. Heart rate control with adrenergic blockade: clinical outcomes in cardiovascular medicine. Vasc Health Risk Manag. 2010;6:387–97.PubMedPubMedCentralGoogle Scholar
  54. 54.
    Dandel M, Weng Y, Siniawski H, Potapov E, Krabatsch T, Lehmkuhl HB, et al. Pre-explant stability of unloading-promoted cardiac improvement predicts outcome after weaning from ventricular assist devices. Circulation. 2012;126(11 Suppl 1):S9–19.PubMedGoogle Scholar
  55. 55.
    Maybaum S, Mancini D, Xydas S, Starling RC, Aaronson K, Pagani FD, et al. Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD working group. Circulation. 2007;115(19):2497–505.PubMedGoogle Scholar
  56. 56.
    Dandel M, Hetzer R. Echocardiographic strain and strain rate imaging--clinical applications. Int J Cardiol. 2009;132(1):11–24.PubMedGoogle Scholar
  57. 57.
    Dandel M, Hetzer R. Myocardial recovery during mechanical circulatory support: weaning and explantation criteria. Heart Lung Vessel. 2015;7(4):280–8.PubMedPubMedCentralGoogle Scholar
  58. 58.
    Stainback RF, Estep JD, Agler DA et al. Echocardiography in the management of patients with left ventricular assist devices: recommendations from the American Society of Echocardiography. J Am Soc Echocardiogr. 2015;28(8):853–909. Scholar
  59. 59.
    Ando M, Nishimura T, Takewa Y, Ogawa D, Yamazaki K, Kashiwa K, et al. What is the ideal off-test trial for continuous-flow ventricular-assist-device explantation? Intracircuit back-flow analysis in a mock circulation model. J Artif Organs. 2011;14(1):70–3.PubMedGoogle Scholar
  60. 60.
    George RS, Sabharwal NK, Webb C, Yacoub MH, Bowles CT, Hedger M, et al. Echocardiographic assessment of flow across continuous-flow ventricular assist devices at low speeds. J Heart Lung Transplant. 2010;29(11):1245–52.PubMedGoogle Scholar
  61. 61.
    Potapov EV, Schweiger M, Krabatsch T. Percutaneous balloon occlusion of a left ventricular assist device outflow cannula to facilitate evaluation of myocardial recovery. J Heart Lung Transplant. 2011;30(11):1300–1.PubMedGoogle Scholar
  62. 62.
    Vierecke J, Hernanedes-Enriquez M, Dandel M, Muller M, Stawowy P, Dreysse S, et al. Percutaneous balloon occlusion of a left ventricular assist device outflow cannula during right heart catheterization with pumpstop as part of the evaluation of myocardial recovery. J Heart Lung Transplant. 2014;33(4):S156–S.Google Scholar
  63. 63.
    Dandel M, Knosalla C, Hetzer R. Contribution of ventricular assist devices to the recovery of failing hearts: a review and the berlin heart Center experience. Eur J Heart Fail. 2014;16(3):248–63.PubMedGoogle Scholar
  64. 64.
    Phan K, Huo YR, Zhao DF, Yan TD, Tchantchaleishvili V. Ventricular recovery and pump explantation in patients supported by left ventricular assist devices: a systematic review. ASAIO J. 2016;62(3):219–31.PubMedGoogle Scholar
  65. 65.
    Birks EJ, George RS, Firouzi A, Wright G, Bahrami T, Yacoub MH, et al. Long-term outcomes of patients bridged to recovery versus patients bridged to transplantation. J Thorac Cardiovasc Surg. 2012;144(1):190–6.PubMedGoogle Scholar
  66. 66.
    Schweiger M, Potapov E, Vierecke J, Stepanenko A, Hetzer R, Krabatsch T. Expeditious and less traumatic explantation of a heartware LVAD after myocardial recovery. ASAIO J. 58(5):542–4.PubMedGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of Internal Medicine, Division of Cardiovascular Health and DiseaseUnivesrity of CincinnatiCincinnatiUSA

Personalised recommendations